Form 4 holding
Director
Drugs Made In America Acquisition II Corp.
- Security class
- Ordinary shares
- Shares / value
- 100,000
- Estimated value
- $987,000
- Report date
- 26 Sep 2025
- Price
- $9.87
- Ownership
- Direct
Catherine Do - Director at Drugs Made In America Acquisition II Corp.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- DMII, DMIIR, DMIIU on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Catherine Do since 01 Aug 2025
Reported holdings for Catherine Do in Drugs Made In America Acquisition II Corp.
Transaction history for Catherine Do in Drugs Made In America Acquisition II Corp.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.